No Detail Found!

Synthesis of polyethylene glycol bis-anti-cancer drug couplings and their anti-tumor activity based on tumor immune dynamic modeling

Author(s)
Shangqing Wang Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Kaisheng Wang The Affiliated 1st Clinical College of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China
Qilong Song The Affiliated 1st Clinical College of Xuzhou Medical University, Xuzhou Medical University, Xuzhou, Jiangsu, China
Feitong Wang The Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China
Abstract
In order to make the drugs can cure the tumor precisely, this paper establishes the tumor immune dynamic model through the differential equation of tumor growth and analyzes the persistence of the tumor immune model. Research on dual anticancer drugs and commonly used coupling methods is carried out to complete the synthesis of polyethylene glycol dual anticancer drug couplers and the antitumor activity is analyzed to derive the degree of inhibition of polyethylene glycol dual anticancer drugs on tumor activity. From the four judging criteria, it was concluded that the polyethylene glycol bis-anti-cancer drug has a better curative effect on tumor cells. Evaluation of polyethylene glycol bis-anti-cancer drugs from four aspects: Apoptosis test, relative tumor growth rate, immunofluorescence staining of tumor tissue sections and antibody endocytosis, it can be found that polyethylene glycol bis-anti-cancer drugs play a role in inhibiting the activity of tumors by 20%, and the proportion of apoptosis is 97.6%, which effectively hinders the growth of tumor cells and reduces the multiplicity of tumor cells. Therefore, the polyethylene glycol bis-anti-cancer drug constructed according to the tumor immune model can effectively cure tumor cancer with targeting, can precisely find the location of the tumor and has high research significance for real-time tumor killing.
Publication Details
Page(s) 1401-1410
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 37, Issue: 6, Year: 2024

Request the full text from PASTIC

Keywords
polyethylene glycol, Apoptosis, Differential Equations, dual anticancer drug, immune dynamic model
References
Alshebremi M,Tomchuck SL,Myers JT,Kingsley DT,Eid S,Abiff M,Bonner M,Saab ST,Choi SH,Huang AY .2023 .Functional tumor cell-intrinsic STING, not host STING, drives local and systemic antitumor immunity and therapy efficacy following cryoablation. J. Immunother. Cancer, 11(8) : 139-142.
Bai Y,Aodeng G,Ga L,Hai W,Ai J .2023 .Research Progress of Metal Anticancer Drugs. , 15(12) : 1002-1012.
Chen SJ,Wang SC,Chen YC,Cancer Pancreatic .2021 .The Immunotherapy for Colorectal Cancer, Lung Cancer. Int. J. Mol. Sci, 22(23) : 12836.
Cibotaru S,Sandu AI,Nicolescu A,Marin L A .2023 .Antitumor activity of PEGylated and TEGylated phenothiazine derivatives: Structure-activity relationship. Int. J. Mol. Sci, 24(6) : 85.
Clark MC,Stein AS .2020 .CD33 directed bispecific antibodies in acute myeloid leukemia. Best practice and research. Clinical haematology, 334 : 101224.
Dai Z,Xie B,Yang B,Chen X,Hu C,Chen Q C .2023 .KANK3 mediates the p38 MAPK pathway to regulate the proliferation and invasion of lung adenocarcinoma cells. Tissue Cell, 80 : 101974.
Huang L .2020 .Chemical synthesis and biological testing of PEG coupling (Lapatinib and allosteric PKI587). , : .
Carmon High P,KS High P .2023 .G protein-coupled receptor-targeting antibody-drug conjugates: Current status and future directions. Cancer Lett., 564 : 216191.
Huang M,Liu S,Song X,Zou X .2022 .Control Strategies for a Tumor-Immune System with Impulsive Drug Delivery under a Random Environment. Acta Mathematica Scientia, 42 : 1141-1159.
Lazebnik T,Aaroni N,Bunimovich-Mendrazitsky S .2021 .PDE based geometry model for BCG immunotherapy of bladder cancer. Biosystems, 200 : 104319.
Meng X,Lei Y,Zhang X,Sun K,Zhang L,Wang Z L .2021 .Cancer immunotherapy: Classification, therapeutic mechanisms and nanomaterial-based synergistic therapy. Appl. Mater. Today, 24 : 101149.
Mirian M,Hariri A,Yadollahi M,Kohandel M M .2022 .Circadian and immunity cycle talk in cancer destination: From biological aspects to in silico analysis. Cancers (Basel), 14(6) : 89-93.
Morton M,Marcu I,Levine M,Cosgrove C,Backes F,O'Malley D and Chambers L F .2023 .Evaluation of efficacy and adverse events after second immunotherapy exposure in endometrial and cervical carcinoma. Obstet, 142(2) : 360-363.
Singh S and Singh K ,Drugs Anticancer .2021 .. , 22(2) : 127-133.
Sun J,Tian Q,Liu M,Su Y,Liu X,Deng Y,Song Y Y .2021 .Evaluation of the antitumor effect and immune response of micelles modified with a polysialic acid-Dα-tocopheryl polyethylene glycol 1000 succinate conjugate. AAPS PharmSciTech, 22(7) : 223.
Underwood DJ,Bettencourt J,Jawad Z J .2022 .The manufacturing considerations of bispecific antibodies. Expert Opin. Biol. Ther, 22(8) : 1043-1065.
Von Rueden SK,Fan TM .2021 .Cancer-immunity cycle and therapeutic interventions-opportunities for including pet dogs with cancer. Front. Oncol., 11 : 773420.
Xiong RH,Yang SQ,Li JW,Shen XK,Jin LM,Chen CY,Yue YT,Yu ZC,Sun QY,Jiang W,Jiang MZ,Wang XY,Song SX,Cao D,Ye HL,Zhao LR,Huang LP,Bu L LP .2024 .Identification of immune-associated biomarker for predicting lung adenocarcinoma: Bioinformatics analysis and experiment verification of PTK6. , 15(1) : 102.
Yan X,Bai L,Qi P,Lv J,Song X,Zhang L X .2023 .Potential effects of regulating intestinal flora on immunotherapy for liver cancer. Int. J. Mol. Sci, 24(14) : 11387.
Yang H,Tan Y,Yang J,Liu Z J .2021 .Extinction and persistence of a tumor-immune model with white noise and pulsed comprehensive therapy. Math. Comput. Simul., 182 : 456-470.
Yang T,Kang L,Li D,Song Y .2023 .Immunotherapy for HER-2 positive breast cancer. Front. Oncol., 13(5) : 442-448.
Yeo SY,Bratke G,Grull H G .2022 .High intensity focused ultrasound for treatment of bone malignancies20 years of history. Cancers (Basel), 15(1) : 65-68.
Yilmaz M and Ravandi F .2020 .The potential role of Bispecific antibodies in acute myeloid leukemia. Best Pract Res Clin Haematol., 33(4) : 101218.
Zhang J,Li F,Lu K,Zhang W .2023 .Recent advances in cold atmospheric plasma for tumor therapy. Process Biochem, 131 : 77-90.
0

Citations

0

Downloads

110

Views